Document Detail


Patient selection for left ventricular assist device therapy.
MedLine Citation:
PMID:  12820732     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patient selection for left ventricular assist device (LVAD) therapy is the most important process in obtaining a successful outcome. Evaluation requires assessing the appropriateness for device implantation based on need and risk of LVAD implant to the patient. Appropriate patients can be selected without the need for invasive hemodynamic measurements and selection can be based on symptoms, appropriateness of medical therapy, and on the need for inotropic therapy. Assessing the risk of LVAD therapy to the patient requires evaluating the degree of organ dysfunction and technical factors. Patients should be offered the option of LVAD therapy if they meet criteria for need, possess the potential for organ recovery, and have appropriate operative risk.
Authors:
Keith D Aaronson; Himanshu Patel; Francis D Pagani
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  75     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-24     Completed Date:  2003-07-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S29-35     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiology, Section of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan 48109, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Heart Failure / therapy
Heart-Assist Devices*
Humans
Patient Selection*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cell transplantation in myocardium.
Next Document:  Bridge to recovery with the use of left ventricular assist device and clenbuterol.